Molecular Mechanisms Mediating Retinal Reactive Gliosis Following Bone Marrow Mesenchymal Stem Cell Transplantation

A variety of diseases lead to degeneration of retinal ganglion cells (RGCs) and their axons within the optic nerve resulting in loss of visual function. Although current therapies may delay RGC loss, they do not restore visual function or completely halt disease progression. Regenerative medicine ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Tassoni, Alessia, Gutteridge, Alex, Barber, Amanda C., Osborne, Andrew, Martin, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Regenerative Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832383/
https://www.ncbi.nlm.nih.gov/pubmed/26175331
http://dx.doi.org/10.1002/stem.2095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832383/
https://www.ncbi.nlm.nih.gov/pubmed/26175331
http://dx.doi.org/10.1002/stem.2095

Ejemplares similares